Open AccessThe outcome of chemotherapeutic regimen by high-risk pre-B-cell protocol in ALL children
Author(s) -
Afshin Fathi,
Mehrdad Mirzarahimi,
Homa Farajkhah
Publication year - 2021
Publication title -
canadian oncology nursing journal
Language(s) - English
Resource type - Journals
eISSN - 2368-8076
pISSN - 1181-912X
DOI - 10.5737/23688076313330333
Subject(s) - regimen , medicine , cog , sepsis , survival rate , complete remission , mortality rate , pediatrics , oncology , chemotherapy , artificial intelligence , computer science
Objective: The aim of this study was to investigate the outcome of chemotherapeutic regimen by high-risk pre-B-cell potocol in ALL children. Methods: The cross-sectional study was conducted on 55 children who were treated with the Children Oncology Group (COG) protocol from September 2010 to February 2015 to evaluate the chemotherapeutic regimen results. Results: There was a complete recovery rate of 76.4% during the first week after treatment. Three-year overall survival was 85.5% and five-year overall survival was 81%. Relapse rate after first remission was 20% and death after relapse was 50%. Thirty percent of total deaths were at the induction period. All of the deceased cases died due to sepsis. Conclusion: Results showed that the survival rate increased. By choosing the COG protocol and by controlling infection in patients without considering the risk group we can improve survival rates.